Oriental Ocean: Fully owned subsidiary obtains medical device registration certificate for parathyroid hormone assay kit.

The Eastern Ocean announced that its wholly-owned subsidiary Aiwuke Biotechnology's self-developed procalcitonin assay kit has recently been approved by the Shandong Provincial Drug Administration and has obtained a medical device registration certificate with a validity period until December 10, 2030. The kit is used for the quantitative detection of procalcitonin content in human serum and other samples. The approval for this product to be marketed enriches Aiwuke Biotechnology's clinical testing product line. However, due to its minimal impact on the company's performance this year, uncertainty in product production and subsequent performance impact, as well as not yet being put into production, sales being influenced by multiple factors, it is currently impossible to predict the specific impact on future performance.